Early stage life sciences company iBIONICS has had “a phenomenal year of growth and learning,” says CEO and co-founder Suzanne Grant.
The company, which is developing a bionic-eye system to restore vision in people with retinal degenerative diseases, has reached combined private and public funding goals of US$2.5 million and added another $1.5 million in grants; it also expects to finalize additional pre-seed financing in the next two quarters.
The firm has secured an exclusive worldwide licence for its prototype and has recently celebrated several other business and technical milestones.
OBJ360 (Sponsored)
What we do BGC Ottawa provides children and youth with a safe place between the realities of home life and the pressures of school — a place of positivity and
A global research powerhouse – right here in Ottawa
Many in the region are unaware, that right here in Ottawa, we have a global research powerhouse. And it’s not a private company, a start up, or a LLC —
Ms. Grant and iBIONICS were also chosen to exhibit at the Accessibility Innovation Showcase at the Invictus Games in Toronto in September.
